PATHWAY ONTOLOGY - ANNOTATIONS
The Pathway Ontology (PW), is currently being developed at the Rat Genome Database. For more information about this vocabulary, please see Petri et al. The rat genome database pathway portal. Database (Oxford). 2011 Apr 8;2011:bar010. Print 2011 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html ).
Term: type 2 diabetes mellitus pathway
Accession: PW:0000208
browse the term
Definition: Diabetes mellitus is characterized by abnormally high levels of glucose in the blood. Hereditary and environmental factors are likely contributors but the exact mechanisms are not well understood. Type 2 diabetes mellitus, characterized by insulin resistance, involves alterations in insulin secretion and signaling and impaired glucose homeostasis pathways.
Synonyms: exact_synonym: NIDDM pathway; T2D pathway; non-insulin-dependent diabetes mellitus pathway
related_synonym: KEGG:04930; type II diabetes mellitus pathway
View Interactive Diagram
G
Abcc8
ATP binding cassette subfamily C member 8
ISO IEA
DNA:missense mutation::A1369S (human)
KEGG RGD
PMID:17259403
rno:04930, RGD:2313628
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982
G
Adipoq
adiponectin, C1Q and collagen domain containing
IEA
KEGG
rno:04930
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
G
Akt2
AKT serine/threonine kinase 2
ISO
RGD
PMID:15166380
RGD:2313408
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
IEA
KEGG
rno:04930
NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
IEA
KEGG
rno:04930
NCBI chr 3:27,779,133...27,944,292
Ensembl chr 3:27,779,166...27,944,285
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
IEA
KEGG
rno:04930
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
IEA
KEGG
rno:04930
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692
G
Cacna1e
calcium voltage-gated channel subunit alpha1 E
IEA
KEGG
rno:04930
NCBI chr13:69,125,048...69,613,795
Ensembl chr13:69,132,305...69,612,983
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
IEA
KEGG
rno:04930
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634
G
Gck
glucokinase
IEA
KEGG
rno:04930
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
G
Hk1
hexokinase 1
IEA
KEGG
rno:04930
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814
G
Hk2
hexokinase 2
IEA
KEGG
rno:04930
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275
G
Hk3
hexokinase 3
IEA
KEGG
rno:04930
NCBI chr17:9,602,119...9,620,038
Ensembl chr17:9,605,016...9,620,037
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
IEA
KEGG
rno:04930
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
G
Ins1
insulin 1
IEA
KEGG
rno:04930
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
G
Ins2
insulin 2
ISO IEA
KEGG RGD
PMID:9809695
rno:04930, RGD:2313694
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
G
Insr
insulin receptor
ISO IEA
KEGG RGD
PMID:9809695
rno:04930, RGD:2313694
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803
G
Irs1
insulin receptor substrate 1
IEA
KEGG
rno:04930
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
G
Irs2
insulin receptor substrate 2
IEA
KEGG
rno:04930
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
G
Irs3
insulin receptor substrate 3
IEA
KEGG
rno:04930
NCBI chr12:24,689,930...24,692,068
Ensembl chr12:24,689,909...24,692,068
G
Irs4
insulin receptor substrate 4
IEA
KEGG
rno:04930
NCBI chr X:110,132,490...110,148,473
Ensembl chr X:110,132,405...110,149,088
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
ISO IEA
polymorphisms in the human gene are linked to altered insulin secretion; E23K polymorphism appears to confer susceptibility to diabetes type-2 in Caucasian population DNA:missense mutation::p.E23K (human)
KEGG RGD
PMID:15565284 PMID:17259403
rno:04930, RGD:2313610 , RGD:2313628
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
G
Mafa
MAF bZIP transcription factor A
IEA
KEGG
rno:04930
NCBI chr 7:109,313,021...109,315,813
Ensembl chr 7:109,313,121...109,315,760
G
Mapk1
mitogen activated protein kinase 1
IEA
KEGG
rno:04930
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk10
mitogen activated protein kinase 10
IEA
KEGG
rno:04930
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100
G
Mapk3
mitogen activated protein kinase 3
IEA
KEGG
rno:04930
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Mapk8
mitogen-activated protein kinase 8
IEA
KEGG
rno:04930
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
G
Mapk9
mitogen-activated protein kinase 9
IEA
KEGG
rno:04930
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
G
Mtor
mechanistic target of rapamycin kinase
IEA
KEGG
rno:04930
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
G
Pdx1
pancreatic and duodenal homeobox 1
IEA
KEGG
rno:04930
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
IEA
KEGG
rno:04930
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
IEA
KEGG
rno:04930
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:108,474,019...108,579,331
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
IEA
KEGG
rno:04930
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
IEA
KEGG
rno:04930
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
IEA
KEGG
rno:04930
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
IEA
KEGG
rno:04930
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762
G
Pik3r5
phosphoinositide-3-kinase, regulatory subunit 5
IEA
KEGG
rno:04930
NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,631,476...53,699,539
G
Pklr
pyruvate kinase L/R
IEA
KEGG
rno:04930
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
G
Prkcd
protein kinase C, delta
IEA
KEGG
rno:04930
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
G
Prkce
protein kinase C, epsilon
IEA
KEGG
rno:04930
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
G
Prkcz
protein kinase C, zeta
IEA
KEGG
rno:04930
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
G
Slc2a2
solute carrier family 2 member 2
IEA
KEGG
rno:04930
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
G
Slc2a4
solute carrier family 2 member 4
IEA
KEGG
rno:04930
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
G
Socs1
suppressor of cytokine signaling 1
IEA
KEGG
rno:04930
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
G
Socs2
suppressor of cytokine signaling 2
IEA
KEGG
rno:04930
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423
G
Socs3
suppressor of cytokine signaling 3
IEA
KEGG
rno:04930
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
G
Socs4
suppressor of cytokine signaling 4
IEA
KEGG
rno:04930
NCBI chr15:23,003,130...23,017,615
Ensembl chr15:23,002,883...23,022,499
G
Tnf
tumor necrosis factor
IEA
KEGG
rno:04930
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all